sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Biomarkers Market Size study, by Product Type (Safety, Efficacy , Validation), by Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Others), by Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Others), and Regional Forecasts 2021-2027

Global Biomarkers Market Size study, by Product Type (Safety, Efficacy...

Home / Categories / Healthcare
Global Biomarkers Market Size study, by Product Type (Safety, Efficacy , Validation), by Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Others), by Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Others), and Regional Forecasts 2021-2027
Global Biomarkers Market Size study,...
Report Code
RO1/103/1867

Publish Date
11/Jan/2022

Pages
214
PRICE
$ 4250/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4950/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5650/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Biomarkers Market , by Region, 2019-2027 (USD Billion)
1.2.2. Biomarkers Market , by Type, 2019-2027 (USD Billion)
1.2.3. Biomarkers Market , by Disease , 2019-2027 (USD Billion)
1.2.4. Biomarkers Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biomarkers Market Dynamics
3.1. Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing funding for biomarkers
3.1.1.2. Increasing prevalence of chronic diseases
3.1.2. Market Restraint
3.1.2.1. Lack of reimbursement policies for biomarkers treatment
3.1.3. Market Opportunities
3.1.3.1. Technological Advancements
Chapter 4. Global Biomarkers Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Biomarkers Market , by Type
5.1. Market Snapshot
5.2. Global Biomarkers Market by Type, Performance - Potential Analysis
5.3. Global Biomarkers Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Biomarkers Market , Sub Segment Analysis
5.4.1. Safety
5.4.2. Efficacy
5.4.3. Validation
Chapter 6. Global Biomarkers Market , by Disease
a. Market Snapshot
6.1. Global Biomarkers Market by Disease, Performance - Potential Analysis
6.2. Global Biomarkers Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)
6.3. Biomarkers Market , Sub Segment Analysis
6.3.1. Cancer
6.3.2. Cardiovascular Diseases
6.3.3. Neurological Diseases
6.3.4. Immunological Diseases
6.3.5. Others
Chapter 7. Global Biomarkers Market , by Application
b. Market Snapshot
7.1. Global Biomarkers Market by Application, Performance - Potential Analysis
7.2. Global Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Biomarkers Market , Sub Segment Analysis
7.3.1. Diagnostics
7.3.2. Drug Discovery and Development
7.3.3. Personalized Medicine
7.3.4. Others
Chapter 8. Global Biomarkers Market , Regional Analysis
8.1. Biomarkers Market , Regional Market Snapshot
8.2. North America Biomarkers Market
8.2.1. U.S. Biomarkers Market
8.2.1.1. Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Disease breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Biomarkers Market
8.3. Europe Biomarkers Market Snapshot
8.3.1. U.K. Biomarkers Market
8.3.2. Germany Biomarkers Market
8.3.3. France Biomarkers Market
8.3.4. Spain Biomarkers Market
8.3.5. Italy Biomarkers Market
8.3.6. Rest of Europe Biomarkers Market
8.4. Asia-Pacific Biomarkers Market Snapshot
8.4.1. China Biomarkers Market
8.4.2. India Biomarkers Market
8.4.3. Japan Biomarkers Market
8.4.4. Australia Biomarkers Market
8.4.5. South Korea Biomarkers Market
8.4.6. Rest of Asia Pacific Biomarkers Market
8.5. Latin America Biomarkers Market Snapshot
8.5.1. Brazil Biomarkers Market
8.5.2. Mexico Biomarkers Market
8.6. Rest of The World Biomarkers Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. F. Hoffmann-la roche ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott laboratories
9.2.3. Epigenomics ag
9.2.4. General electric
9.2.5. Johnson & Johnson services, inc.
9.2.6. Thermo fisher scientific, Inc.
9.2.7. Bio-rad laboratories, inc.
9.2.8. Siemens healthineers ag
9.2.9. Qiagen

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com